SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories trades in green on BSE

11 Jun 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5317.15, up by 26.50 points or 0.50% from its previous closing of Rs. 5290.65 on the BSE.

The scrip opened at Rs. 5305.00 and has touched a high and low of Rs. 5330.70 and Rs. 5288.20 respectively. So far 2796 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3815.80 on 07-Jul-2020.

Last one week high and low of the scrip stood at Rs. 5330.70 and Rs. 5151.00 respectively. The current market cap of the company is Rs. 88006.95 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.

Rockwell Industries has entered into strategic partnership with Dr. Reddy's Laboratories, to provide its World Health Organisation - Performance, Quality and Safety certified Covid-19 vaccine freezersto enable storage of Sputnik V vaccine in India.

The vaccine freezer plays a very critical role in the safety of vaccines and its potency as Russias Sputnik V vaccine, made available in India through Dr Reddy's, requires a temperature range of minus -18 degrees celsius, to keep the vaccine stable and potent. In addition, Rockwell will provide end to end logistics and after sales service support for the vaccine freezers across India.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×